About AC Immune (ACIU)
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, dia... Read more
- USD2.48
- USD2.55
- USD2.38
- USD3.98
- 19.20%
- 33M
- 134.04k
- 244M
- 1.43
- -22.30%
Stock News
7 hours ago
When Playing It Safe Isn't Safe: Managing Reinvestment Rate Risk
SeekingAlpha
7 hours ago
China Gold Market Update: Wholesale Demand Fell In August
SeekingAlpha
7 hours ago
The Commodities Feed: Oil Under Pressure Despite API Reporting Oil Inventory Draws
SeekingAlpha
8 hours ago
Beyond 60/40: How Adaptive Asset Allocation Outperforms Traditional Portfolios
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
